Search

Displaying results 3021 - 3030 of 10000 in total
  1. Drug

    Endostatin

    go.drugbank.com/drugs/DB06423
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  2. Drug

    Cefoperazone

    go.drugbank.com/drugs/DB01329
    ApprovedInvestigationalWithdrawn

    It is a third-generation antiobiotic agent and it is used in the treatment of various bacterial infections caused by susceptible organisms in the body, including respiratory tract infections, peritonitis … Cefoperazone is a semisynthetic broad-spectrum cephalosporin proposed to be effective against <i>Pseudomonas</i> infections.

  3. Drug

    Bioymifi

    go.drugbank.com/drugs/DB17493
    Experimental

    Upon binding to the death receptor 5 (DR5) on cancer cells, bioymifi triggers apoptosis, possibly through a caspase-dependent pathway. Bioymifi is currently being investigated as an anti-tumor agent. … Bioymifi is a small molecule that acts as a tumor necrosis factor-related apoptosis-induced ligand (TRAIL) mimetic.

  4. Drug

    ZYC300

    go.drugbank.com/drugs/DB04986
    Investigational

    ZYC300 is a plasmid DNA of CYP1B1 encapsulated in biodegradable poly-DL-lactide-coglycolide microparticles. … It is designed as a vaccine, intended to increase immune system sensitivity to CYP1B1, an enzyme highly prevalent in tumor cells.

  5. Drug

    Crisaborole

    go.drugbank.com/drugs/DB05219
    ApprovedInvestigational

    Crisaborole is a novel oxaborole approved by FDA on December 14, 2016 as Eucrisa, a topical treatment of for mild to moderate atopic dermatitis. … It is currently under development as topical treatment of psoriasis.

  6. Drug

    Acetergamine

    go.drugbank.com/drugs/DB21015
    Experimental

    Acetergamine is a small molecule drug. Acetergamine has a monoisotopic molecular weight of 297.18 Da.

    Categories: Heterocyclic Compounds with 4 or More Rings
  7. Drug

    Pomaglumetad methionil

    go.drugbank.com/drugs/DB05096
    Investigational

    Further studies are planned or are ongoing to learn more about the safety and effectiveness, including determining an optimal therapeutic dose for LY2140023. … LY2140023 is an investigational drug from Lilly, which is being developed as a new treatment option for schizophrenia.

  8. Drug

    Cobamamide

    go.drugbank.com/drugs/DB11191
    ApprovedNutraceutical

    Cobamamide is one of the active forms of vitamin B12 that is also known as _adenosylcobalamin_ or _dibencozide_. … It is therefore important to treat vitamin B12 deficiency with a combination of MeCbl and AdCbl or hydroxocobalamin or cobalamin [L2054].

    Categories: Heterocyclic Compounds with 4 or More Rings
  9. Drug

    Lergotrile

    go.drugbank.com/drugs/DB21016
    Experimental

    Lergotrile is a small molecule drug. Lergotrile has a monoisotopic molecular weight of 299.12 Da.

    Categories: Heterocyclic Compounds with 4 or More Rings
  10. Drug

    Etisulergine

    go.drugbank.com/drugs/DB19706
    Experimental

    Etisulergine is a small molecule drug. Etisulergine has a monoisotopic molecular weight of 376.19 Da.

    Categories: Heterocyclic Compounds with 4 or More Rings